Laws, Ethics, and PsychiatryDesire for death near the end of life: the role of depression, anxiety and pain
Introduction
Requests to hasten death as well as the desire for death have become major topics in the palliative care literature [1], [2], [3]. Previous studies have found that the desire of patients with terminal cancer for death has been linked to multidimensional factors including psychiatric disorders, suicidal ideation, physical suffering and pain [2], [4], [5], [6]. The conditions that are most commonly mentioned when discussing psychological issues near the end of life are depression and pain [7]. Depression is a significant symptom for approximately 25% of cancer patients but is frequently unrecognized and untreated, while around 35% of cancer patients, during the induction and consolidation phase of treatment, have been found to have high levels of anxiety and depression [8]. Pain is also a common occurrence in cancer patients and is often inadequately treated. Moreover, pain and depression often co-occur and their implications can be profound [9], [10]. Patients with advanced cancer who have persistent pain are twice as likely to suffer from a psychiatric complication (depression or anxiety) as those without pain [11]. Nevertheless, some authors have suggested that emotional disturbance is more likely to be a consequence than a cause of chronic pain [12], [13].
Chochinov et al. [5] found that the desire for hastened death was significantly related to both severe pain and the presence of depression. Still, other studies have failed to observe a significant role of pain in causing desire for hastened death [14]. Furthermore, virtually no research has examined the role of anxiety in the desire for hastened death.
Anxiety is quite common in patients receiving palliative care and can reduce a patient's tolerance for physical distress, especially pain [15]. Symptoms of unresolved past losses, acute stress and even posttraumatic stress disorder may occur when a person is facing the end of life [7]. However, because of the overlap between anxiety and depression, distinguishing between these two constructs is often difficult [16], [17]. A high concordance between the two symptoms in cancer patients suggests that both will need to be attended [16].
The current study attempted to further this growing literature on desire for hastened death by assessing the relationships between depression, anxiety, pain and desire for hastened death in a sample of Greek adults who are terminally ill. In addition, because most of the research on desire for hastened death have focused on American samples, our study of terminally ill cancer patients from Greece has the potential to identify cultural differences in the factors that drive desire for hastened death.
Section snippets
Patients and methods
The current study was performed at a palliative care unit of the Areteion University Hospital in Athens, Greece, between June and November 2003. One hundred ninety-one terminally ill cancer patients were treated in this unit for pain relief and cancer-related symptoms. Forty-eight of these patients were excluded from the study because they were cognitively impaired or were too sick to communicate.
Eligibility criteria for participation were age over 18 years, a diagnosis of terminal cancer and
Procedures and measurements
Patients were interviewed by a member of the palliative care unit in order to elicit background medical history, demographic data, prior mental health and current medical condition. The evaluations were completed in the patients' first visit to the unit in a brief interview. The dependent variable in this study was the Greek version of the Schedule for Attitudes Toward Hastened Death (G-SAHD), a 20-item true/false measure of the desire for hastened death that has demonstrated a high degree of
Statistical analysis
The relationship between HADS-Depression and HADS-Anxiety scores, pain (G-BPI) and desire for hastened death (G-SAHD) was examined using Spearman's ρ because of the skewed distribution of SAHD scores [18]. Univariate analysis was performed using Spearman's correlations coefficients and independent-samples t test. A stepwise multiple regression model predicting G-SAHD scores was then used, with average pain, pain interference, HADS-Depression and HADS-Anxiety scores, strong and mild opioids,
Results
Descriptive statistics are presented in Table 2. The average total score on the G-SAHD for this sample was 2.90±3.70, a median of 2 (range, 0–17). The distribution of scores was positively skewed, with few individuals endorsing large numbers of items and most patients (70%) endorsing no, one or two items. In this sample, 8.3% of the patients had a high desire for death while an additional 5% of patients had a strong desire for death. Approximately 78% of the sample had a SAHD total score of 3
Discussion
Feelings of depression, hopelessness and anxiety are common in individuals who approach the terminal phase of an illness [17]. Whereas many patients manage to avoid feeling distressed as they approach death, others have a great sense of despair during their final weeks or months of life. End-of-life despair could manifest itself as a general feeling of hopelessness or in the extreme might develop into a desire for hastened death or thoughts of suicide [17]. This study sought to examine
References (25)
- et al.
Dignity in the terminally ill: a cross-sectional, cohort study
Lancet
(2002) Is emotional disturbance a precipitator or a consequence of chronic pain?
Pain
(1990)- et al.
Negative affect and the experience of chronic pain
J Psychosom Res
(1992) - et al.
Desire for death and requests to hasten death of Japanese terminally ill cancer patients receiving specialized inpatient palliative care
J Pain Symptom Manage
(2004) Euthanasia and physician-assisted suicide: a review of the empirical data from the United-States
Arch Intern Med
(2002)- et al.
Depression, hopelessness, and the desire for hastened death in terminally ill patients with cancer
JAMA
(2000) - et al.
Factors associated with the wish to hasten death: a study of patients with terminal illness
Psychol Med
(2003) - et al.
Is it normal for terminally ill patients to desire death?
Am J Psychiatry
(1986) - et al.
Desire for death in the terminally ill
Am J Psychiatry
(1995) - et al.
Psychosocial issues near the end of life
Aging Ment Health
(2002)
How do palliative medicine physicians assess and manage depression
Palliat Med
The impact of pain and impaired role performance on distress in persons with cancer
Can J Psychiatry
Cited by (51)
Determination of the refractory nature of terminal suffering by palliative care unit physicians?
2022, Medecine PalliativeThe wish to hasten death: Definition, determinants, issues and perspectives
2021, Bulletin du CancerPalliative care education and its effectiveness: a systematic review
2021, Public HealthCitation Excerpt :Apart from physical symptom management, there are two PCE programs45,49 that touched on the topic of depression for the dying. Research has identified that end-of-life patients often experience feelings of hopelessness with symptoms of anxiety and depression, leading to suicidal ideation in the worst cases.69,70 This limitation of the PCE programs warrants future research into this area.
Dyspnea in Hospice and Palliative Medicine
2020, Physician Assistant ClinicsCitation Excerpt :Although the predominant pathologies contributing to dyspnea remain cardiopulmonary in origin, patients nearing end of life report increasing dyspneic symptoms regardless of a cardiopulmonary cause, which is thought to be attributed to the generalized muscle fatigue, weakness, and debility noted in the dying process.2 Research has shown a correlation between anxiety, panic disorders, and panic attacks with respiratory changes including hyperventilation and increased desire of patients to hasten death in the dying patient.10,11 In these patients with preexisting psychological components, they experience dyspnea at a more severe level compared with those without.10
- 1
Tel.: +1 718 817 3794; fax: +1 718 817 3699.
- 2
Tel.: +30210 7707669; fax: +30210 7488437.
- 3
Tel.: +30210 7286137; fax: +30210 7488437.